SkinVision collaborates on pivotal trial to improve Access to Dermatology Care in the United States. Mar 16, 2026, 09:45 ET Mayo Clinic and SkinVision have entered a research collaboration to support U.S. FDA requirements and expand access to research-backed skin health guidance in the United States AMSTERDAM, March 16, 2026 /PRNewswire/ - SkinVision, a global leader in AI-powered skin health services, today announced a research collaboration with Mayo Clinic to conduct a pivotal trial required by the U.S. Food and Drug Administration (FDA) to support the company's U.S. regulatory pathway. The collaboration is conducted under a research collaboration agreement with Mayo Clinic, which governs the exchange of scientific expertise and supports the execution of an innovative study. The incidence of melanoma and non-melanoma skin cancer continues to rise, while timely access to dermatologic care remains limited for many patients across the United States. National workforce shortages, insurance-related barriers, and the uneven geographic distribution of dermatologists contribute to long waiting times and delayed evaluations. These system-level challenges are compounded by socioeconomic factors - income, education level, and transportation access - that disproportionately affect vulnerable populations and increase the risk of later-stage diagnosis and poorer outcomes. The pivotal study will evaluate the performance and intended use of the SkinVision app's AI-based assessment for skin spots, while exploring how digital tools may help improve access to dermatology guidance across the United States. Advancing Clinical Evidence and Regulatory Readiness This research collaboration represents an important step in SkinVision's regulatory and scientific development, with the goal of generating robust clinical evidence to support FDA clearance and to validate the technology app within the U.S. population. Improving Access to Dermatology Care SkinVision is designed to help people document and monitor skin spots of concern by guiding them in capturing high-quality photos and relevant information during a skin self-examination. The app provides an informational indication when a spot may benefit from evaluation by a qualified healthcare professional. SkinVision is committed to delivering accessible, research-backed, and affordable digital skin health solutions to individuals and communities across the United States. A Major Milestone for SkinVision Erik de Heus, CEO of SkinVision, said: "This pivotal trial marks a significant scientific and regulatory milestone for SkinVision. We are excited to collaborate with Mayo Clinic on this research as we continue to build clinical evidence to support our technology. This study represents an important step toward making trusted, AI-powered skin health guidance available to users across the United States." Mayo Clinic has a financial interest in the technology referenced in this press release. Mayo Clinic will use any revenue it receives to support its not-for-profit mission in patient care, education and research. About SkinVision SkinVision is a CE-certified medical device app (EU MDR Class IIa) that helps people document and monitor skin spots of concern by analyzing photos taken during a skin self-exam. Its clinically validated technology provides an informational indication when a spot may warrant further evaluation by a qualified healthcare professional. Founded in 2012 and headquartered in Amsterdam, SkinVision has supported more than 6 million skin checks for over 3 million users worldwide. SkinVision does not diagnose skin cancer and does not replace a doctor or dermatologist. For more information, visit www.skinvision.com. Note for the press CEO Erik de Heus and Head of Clinical, Regulatory and Quality Affairs Wim Laloo are available for interviews. Please contact Maartje ([email protected]) if you would like to speak with them. Photos are available in the press kit: https://media.dev.skinvision.xyz/2026/02/27205747/press-kit-2026.zip. SOURCE SkinVision

Benenden Health partners with SkinVision. Skin cancer detection for members. Healthcare provider, Benenden Health, has added to its preventative offering through a partnership with skin cancer detection service, SkinVision. The provider said SkinVision's services will be available immediately to its members, with new members able to access the services from the first day of their membership. SkinVision is a mobile application designed to help people detect skin cancer early. It analyses photos of moles and skin spots to assess the risk of skin cancer, by "combining a clinically validated artificial intelligence (AI) algorithm with the expertise of dermatologists". Erik de Heus, CEO, SkinVision, said that Benenden Health members can routinely check their skin with the app and get a qualified risk assessme...

Spot it early: UniMed's skin-check app benefit that gives your skin health a head-start. Share this. UniMed has added a powerful new preventative health tool to all their Health Plans as an Active Benefit. It's a skin-check app from SkinVision, that helps you keep on top of changes to your skin from anywhere, at any time. UniMed have partnered with SkinVision to provide health plan holders with access to a mobile app that will enable you to take control of your skin health and support you in detecting skin cancer early. SkinVison are a health-tech company that developed the mobile app that uses AI and dermatologists to provide a risk indication for skin spots from a user's photo and stores images to track changes over time. Whilst it's not a diagnostic tool, it is a powerful preventative one designed to empower users to monitor their skin and know when to seek medical advice from a professional. If you have a UniMed Health Plan, this benefit gives you quick, AI-supported assessments to help spot potential issues early. Here's what makes this new benefit worth paying attention to. Why early skin checks matter New Zealand has some of the world's highest rates of skin cancer, with around 80% of cases linked to UV exposure. Its climate, outdoor lifestyles, and high summer UV levels all increase risk and even small changes in your skin can be important. Skin cancer is the most common cancer in New Zealand and accounts for around 80% of new cancer diagnoses each year. Its melanoma death rates are the highest in the world, driven by three key environmental factors: * Intense UV Radiation: Its geographic location places HealthCarePlus directly under the ozone hole, exposing HealthCarePlus to exceptionally high levels of ultraviolet (UV) radiation. * Clear Skies: Unlike countries with urban smog that can filter UV rays, New Zealand's clean, clear air offers little protection from the sun. * Proximity to the Sun: During summer, the Earth's orbit brings the southern hemisphere closer to the sun than the northern hemisphere experiences in its summer, intensifying UV exposure. In 2022, 535 people died of skin cancer (317 deaths were from melanoma and 218 deaths from non-melanoma). This means that more New Zealanders die each year from melanoma than on its roads. The good news? When detected early, most skin cancers are highly treatable. That's why regular skin checks whether at home, with your GP, or using digital tools like this app play such a crucial role in protecting your long-term health. What to keep an eye out for Skin cancer doesn't always look the same, but there are key changes worth monitoring Warning signs may include: * A new spot on the skin that appears suddenly or a spot that looks or feels different from surrounding spots. * A spot that changes in size, shape, or colour. * A spot that has irregular or fuzzy borders, or mixes multiple colours (brown/black/red/pink). * A spot that itches, bleeds, crusts or doesn't heal. If you notice any of these, or if something doesn't look or feel right, it's important to book a skin-check with a dermatologist. How early detection made the difference The SkinVision app uses advanced AI technology combined with dermatology-expert oversight to assess moles and other skin spots. With this new UniMed benefit, you have access to a simple, supportive way to stay proactive about your skin health: * Scan suspicious spots, * Receive an immediate risk assessment and recommendations for next steps, putting you in control of your skin health from home. * Store images to track changes over time, making it easier to notice subtle shifts you might otherwise miss. By spotting an issue early, you may avoid a more serious diagnosis and get access to treatment sooner. Eligibility and next steps Eligible plans: This skin-check benefit is only available to Members with Primary Care plans (Primary Care, Primary Care Extra and #care4U) and Hospital Select plan. Not covered? If you don't currently hold one of these policies, you'll need to purchase the plan first before you can access the benefit. You can find out more about these plans and sign up here. A Final Thought from Us Skin health can change quickly but, w ith tools like UniMed's skin-check app so can your ability to catch things early. Now taking care of your skin doesn't have to be complicated, small moments of proactive action can make a meaningful difference later. If this benefit is available to you, it's well worth trying it out. Your future self will thank you. Written by: Alan Sharpe Alan is a key member of the HealthCarePlus leadership team. With over 30 years experience in marketing and customer service roles he is a passionate advocate for the union movement and HealthCarePlus's mission to create real, lasting value for their members